参芪扶正注射液联合营养支持辅助治疗对老年局部晚期鼻咽癌放化疗患者的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

贵州省中医药管理局中医药、民族医药科学技术研究课题(QZYY-2019-044);2020年贵州省卫生健康委科学技术基金项目(GZWJKJ2020-1-035 )


The effect of Shenqi Fuzheng injection combined with nutritional support adjuvant therapy on the elderly patients with local advanced imperial pharyn geal cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨参芪扶正注射液联合营养支持辅助治疗对老年局部晚期鼻咽癌放化疗患者耐受性、营养状态、细胞免疫、Th1/Th2、外周血循环肿瘤细胞的影响。方法 选取2021年1月—2023年1月于贵州医科大学附属医院行诱导化疗加同期放化疗治疗的120例局部晚期鼻咽癌患者,将患者匹配分为A组(单纯放化疗,40例)、B组(放化疗期间给予营养支持,40例)、C组(放化疗期间给予静脉滴注参芪扶正注射液联合营养支持,40例)。观察3组治疗完成情况、不良反应,并比较3组干预前后营养状态、细胞免疫、Th1/Th2和外周血循环肿瘤细胞变化和差异。结果 3组患者均完成放化疗治疗,C组放疗中断≥5 d、放疗总疗程≥45 d比例低于A组(P<0.017),同步完成率高于A组(P<0.017)。C组Ⅲ度及以上口腔黏膜炎、白细胞减少、乏力、重度贫血、脱发、恶心呕吐发生率低于A组(P<0.017)。C组Ⅲ度及以上口腔黏膜炎、乏力发生率低于B组(P<0.017),C组放化疗后疗效高于B组和A组(均P<0.017)。A组治疗后CD3+ T细胞、CD4+ T细胞、CD4+/ CD8+、ALB、PA、Hb、TRF、Th1、Th1/Th2、外周血循环肿瘤细胞数量较治疗前降低,Th2较治疗前增高(均P<0.05);B组和C组治疗后CD3+ T细胞、CD4+ T细胞、CD4+/ CD8+、ALB、PA、Hb、TRF、Th1、Th1/Th2较治疗前增高,外周血循环肿瘤细胞数量、Th2较治疗前降低(均P<0.05);C组治疗后CD3+ T细胞、CD4+ T细胞、CD4+/ CD8+、血清白蛋白(ALB)、血清前白蛋白(PA)、Hb、血清转铁蛋白(TRF)、Th1、Th1/Th2高于B组和A组(均P<0.05),外周血循环肿细胞数量、Th2低于B组和A组(P<0.05)。结论 参芪扶正注射液和营养支持可改善老年局部晚期鼻咽癌放化疗患者营养状态和免疫功能,维持Th1/Th2平衡,减少外周血循环肿瘤细胞数量,提高放化疗疗效和治疗耐受性,降低放化疗不良反应发生率

    Abstract:

    Objective To investigate the effects of Shenqi Fuzheng Injection combined with nutritional support on tolerance, nutritional status,cellular immunity,Th1/Th2 and peripheral blood circulating tumor cells in patients with locally advanced nasopharyngeal carcinoma undergoing radiotherapy and chemotherapy. Method A total of 120 patients with locally advanced nasopharyngeal carcinoma who received induction chemoradiotherapy in our hospital from January 2021 to January 2023 were selected and divided into three groups by random number table method. Group A (40 cases) received radiotherapy and chemotherapy alone, group B (40 cases) received nutritional support during radiotherapy and chemotherapy, and group C (40 cases) received intravenous infusion of Shenqi Fuzheng injection combined with nutritional support during radiotherapy and chemotherapy. The completion of treatment, adverse reactions and efficacy of radiotherapy in the three groups were observed, and the changes and differences of nutritional status,cellular immunity,Th1/Th2 and peripheral blood circulating tumor cells before and after intervention were compared. Results All patients in the three groups completed radiotherapy and chemotherapy. The proportion of radiotherapy interruption ≥5d and total course ≥45d in group C was lower than that in group A (P<0.017), and the synchronous completion rate was higher than that in group A (P<0.017). The incidence of oral mucositis and leukopenia with grade Ⅲ or above was lower than that in group A (P<0.017). There was no significant difference in the efficacy of induced chemoradiotherapy among the three groups (P>0.05). The CD3+ T cells, CD4+ T cells, CD4+/ CD8+, ALB, PA, HGB, TRF, number of Th1, Th1/Th2 and peripheral blood circulating tumor cells in group A was decreased compared with before treatment (P<0.05), Th2 was increased compared with before treatment (P<0.05). CD3+ T cells, CD4+ T cells, CD4+/ CD8+, ALB, PA, HGB, TRF, Th1 and Th1/Th2 in groups B and C were increased after treatment compared with before treatment (P<0.05),and the number of circulating hematoma cells and Th2 in peripheral blood were lower than before treatment (P<0.05). After treatment, CD3+ T cells, CD4+ T cells, CD4+/ CD8+, ALB, PA, HGB, TRF, Th1 and Th1/Th2 in group C were higher than those in groups B and A (P<0.05), and the number of peripheral blood circulating hematoma cells and Th2 in group C were lower than those in groups B and A (P<0.05). Conclusion Shenqi Fuzheng injection combined with nutritional support can improve nutritional status and cellular immune function, maintain Th1/Th2 balance, reduce the number of circulating tumor cells in peripheral blood, improve treatment tolerance and reduce the incidence of adverse reactions in patients with locally advanced nasopharyngeal carcinoma

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-02-19
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司